亨鑫科技(01085.HK)預計年度淨利同比減少45%-55%
格隆匯 2 月 19日丨亨鑫科技(01085.HK)公佈,儘管受到COVID-19疫情影響,集團仍可自截至2020年12月31日止年度持續營運中取得盈利。然而,該未經審核淨利潤預期將較截至2019年12月31日止十二個月的經審核綜合淨利潤約人民幣1.13億元減少約45%至55%之間。
隨着COVID-19疫情在中國內地於2020年第二季度之後較為穩定,商業及經濟活動也逐步恢復,集團能夠由其生產活動及業務中產生利潤,並彌補2020年第一季度產生的虧損,但就該報吿期來説業績仍有一定下滑。鑑於中國內地電訊產品之需求持續強勁,預期2021年新增5G基站數量將比該報吿期大幅增加,集團深信集團的產品市場需求未來將會維持強勁。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.